HIV-exposed-uninfected infants have increased inflammation and monocyte activation

Sahera Dirajlal-Fargo1,2,3, Marisa M Mussi-Pinhata4, Adriana Weinberg5

  • 1University Hospitals Cleveland Medical Center.

AIDS (London, England)
|January 17, 2019
PubMed

Insights

HIV-exposed-uninfected infants show heightened inflammation and monocyte activation at birth, persisting to six months. This inflammation may contribute to increased illness and impaired growth in these infants.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • HIV-exposed-uninfected (HEU) infants experience higher rates of infectious illness and mortality.
  • Limited understanding exists regarding inflammation and monocyte activation levels in HEU infants.

Purpose of the Study:

  • To investigate and compare levels of inflammation and monocyte activation markers in HEU infants versus HIV-unexposed infants.
  • To determine the persistence of these markers from birth to six months of age.

Main Methods:

  • Plasma samples from 86 HEU and 88 HIV-unexposed mother-infant pairs were analyzed at birth and 6 months.
  • Assayed inflammatory markers included IL-6, sTNF-RI, sTNF-RII, sCD14, sCD163, IP-10, VCAM, oxLDL, D-dimer, and hs-CRP.
  • Maternal HIV-RNA levels and infant outcomes (gestational age, weight, height) were recorded.

Main Results:

  • HEU infants exhibited higher inflammatory markers at birth, with soluble TNFα receptor I (sTNF-RI) and IL-6 persisting at 6 months.
  • HEU infants had lower mean gestational age and birth weight compared to controls.
  • Elevated hs-CRP and IP-10 at birth correlated with lower infant weight at birth and 6 months.

Conclusions:

  • HEU infants present with heightened inflammation and monocyte activation at birth, which can persist to 6 months.
  • This inflammation is not directly linked to the mother's inflammatory status.
  • Inflammation may be a contributing factor to increased infectious morbidity and poor growth observed in HEU infants.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.0K
Increasing Function01:18

Increasing Function

An increasing function exhibits a rise in output values as input values increase. This behavior is depicted graphically as a curve or line that slopes upward from left to right. Such a function satisfies the condition that if x1 < x2, then f(x1) < f(x2), indicating that the function values grow with increasing inputs. This concept is fundamental in understanding growth trends across various domains, such as population dynamics, financial investments, or resource consumption.The...
391
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.5K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
293
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
137.8K